LDH-B Antibodies

Santa Cruz Biotechnology offers a broad range of LDH-B monoclonal antibodies for research applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LDH-B, or lactate dehydrogenase B, plays a crucial role in the conversion of pyruvate to lactate during anaerobic respiration, making it essential for cellular energy production, particularly in tissues with high metabolic demands. Its expression levels can serve as important biomarkers in various diseases, including cancer and cardiovascular conditions, highlighting its significance in both basic and clinical research. LDH-B monoclonal antibodies enable precise detection and quantification of LDH-B in diverse experimental settings. Understanding LDH-B expression patterns and activity helps researchers uncover new insights into cellular metabolism and disease progression. LDH-B monoclonal antibodies support investigations into energy metabolism pathways across different tissue types. Researchers can leverage LDH-B monoclonal antibodies to examine how metabolic alterations influence disease development and potential therapeutic interventions. The high specificity of LDH-B monoclonal antibodies allows for reliable protein detection in complex biological samples. Santa Cruz Biotechnology's LDH-B monoclonal antibodies contribute to advancing metabolic research and therapeutic development across the scientific community.